Abstract
Background: With the advent of changes in lifestyle of people all around the world, cancer cases have been showing an exponential rise. Researchers from varied fields have been trying to solve this tricky issue.
Methods: We undertook a systematic search of bibliographic databases of peer-reviewed research literature to evaluate the holistic blend of modern and traditional approaches, especially the Ayurvedic perspective of treatment of cancer along with the effect of our diet and lifestyle on the management (both prevention and cure) of cancer.
Results: On the basis of extensive literature survey, it was found that Ayurveda as one of the ancient medicinal systems had been very well documented for utilizing its best practices for the treatment of various diseases including cancer, by utilization of several herbal plants and dietary interventions as therapeutics. Active components present in various herbs, which interfere with certain molecular targets to inhibit carcinogenesis are also summarized. Further, beneficial effects of yoga and exercise on psychological distress, cancer-related fatigue and global side-effects as well as their mechanism of action are also discussed. In addition, we recapitulate an upcoming field of Ayurgenomics to understand the possible correlation of Prakriti with genetics as well as epigenetics.
Conclusion: Both genetic as well as environmental factors have shown their linkage with cancer. Substantial advancements in the field of targeted therapies have opened new horizons for the cancer patients. To fight with this grave situation, a combination of ancient and modern medicinal systems seems to be the need of the hour.
Keywords: Cancer, ayurveda, cancer treatment, effect of diet, ancient cancer remedies, ayurgenomics.
Graphical Abstract
[1]
Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther 2009; 1(2): 1.
[2]
Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995; 92(12): 5258-65.
[3]
Kuper H, Adami HO, Boffetta P. Tobacco use, cancer causation and public health impact. J Intern Med 2002; 251(6): 455-66.
[6]
Kushi LH, Byers T, Doyle C, et al. American cancer society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2006; 56(5): 254-81.
[7]
Roukos DH. Genome-wide association studies: How predictable is a person’s cancer risk? Expert Rev Anticancer Ther 2009; 9(4): 389-92.
[8]
Milholland B, Auton A, Suh Y, Vijg J. Age-related somatic mutations in the cancer genome. Oncotarget 2015; 6(28): 24627-35.
[9]
Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, Capella G. Recent advances in cancer therapy: An overview. Curr Pharm Des 2010; 16(1): 3-10.
[10]
Emens LA, Middleton G. The interplay of immunotherapy and chemotherapy: harnessing potential synergies. Cancer Immunol Res 2015; 3(5): 436-43.
[11]
Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: An update. CA Cancer J Clin 2011; 61(4): 250-81.
[12]
Amreddy N, Babu A, Muralidharan R, et al. Chapter five-recent advances in nanoparticle based cancer drug and gene delivery. Adv Cancer Res 2018; 137: 115-70.
[13]
Wicki A, Witzigmann D, Balasubramanian V, et al. Nanomedicine in cancer Therapy: Challenges, opportunities and clinical applications. J Control Release 2015; 200: 138-57.
[14]
Sudeep HV, Gouthamchandra K, Venkatesh BJ, Prasad KS. Viwithan, a Standardized Withania somnifera root extract induces apoptosis in murine melanoma cells. Pharmacogn Mag 2018; 13(Suppl. 4): S801-6.
[15]
Mukherjee PK, Harwansh RK, Bahadur S, et al. Development of ayurveda - Tradition to trend. J Ethnopharmacol 2017; 197: 10-24.
[16]
Lv L, Liu B. Anti-tumor effects of bakuchiol on human gastric carcinoma cell lines are mediated through PI3K/AKT and MAPK signaling pathways. Mol Med Rep 2017; 16(6): 8977-82.
[17]
Patwardhan B, Vaidya AD, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci 2004; 86(6): 789-99.
[19]
Mukherjee PK, Nema NK, Venkatesh P, Debnath PK. Changing scenario for promotion and development of Ayurveda–way forward. J Ethnopharmacol 2012; 143(2): 424-34.
[20]
Chopra A, Doiphode VV. Ayurvedic medicine: Core concept, therapeutic principles, and current relevance. Med Clin North Am 2002; 86(1): 75-89.
[21]
Mishra LC, Singh BB, Dagenais S. Ayurveda: A historical perspective and principles of the traditional healthcare system in India. Altern Ther Health Med 2001; 7(2): 36.
[22]
Jayasundar R. Ayurveda: A distinctive approach to health and disease. Curr Sci 2010; 98(7): 908-14.
[24]
Adhvaryu MR, Reddy N, Parabia MH. Anti-tumor activity of four Ayurvedic herbs in Dalton lymphoma ascites bearing mice and their short-term in vitro cytotoxicity on DLA-cell-line. Afr J Tradit Complement Altern Med 2008; 5(4): 409-18.
[26]
Mehta AK. PD ayurveda today: Ayurveda Cancer. 2010; (Available from.pdayurvedatoday.com/ayurveda-and-cancer.pdf
[27]
Subbarayappa BV. The roots of ancient medicine: a historical outline. J Biosci 2001; 26(2): 135-43.
[28]
Deshmukh V, Kulkarni A, Bhargava S, et al. Effectiveness of combinations of Ayurvedic drugs in alleviating drug toxicity and improving quality of life of cancer patients treated with chemotherapy. Support Care Cancer 2014; 22(11): 3007-15.
[29]
Ramamoorthy A, Janardhanan S, Jeevakarunyam S, Jeddy N, Eagappan S. Integrative oncology in indian subcontinent: An overview. J Clin Diagn Res 2015; 9(3): 1-3.
[30]
Vyas P, Thakar AB, Baghel MS, Sisodia A, Deole Y. Efficacy of Rasayana Avaleha as an adjuvant to radiotherapy and chemotherapy in reducing adverse effects. Ayu 2010; 31(4): 417.
[31]
Smith HR. Depression in cancer patients: Pathogenesis, implications and treatment. Oncol Lett 2015; 9: 1509-14.
[32]
Pearce A, Haas M, Viney R, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS One 2017; 12(10): e0184360.
[34]
Ichikawa H, Nakamura Y, Kashiwada Y, Aggarwal BB. Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr Pharm Des 2007; 13(33): 3400-16.
[35]
Garodia P, Ichikawa H, Malani N, Sethi G, Aggarwal BB. From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol 2007; 5(1): 25-37.
[37]
Balachandran P, Govindarajan R. Cancer: An ayurvedic perspective. Pharm Res 2005; 51(1): 19-30.
[38]
Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2000; 71(1): 23-43.
[39]
Mahmoud GI. Biological effects, antioxidant and anticancer activities of marigold and basil essential oils. J Med Plants Res 2013; 7(10): 561-72.
[40]
Ghafoorunissa. Requirements of dietary fats to meet nutritional needs & prevent the risk of atherosclerosis-an Indian perspective. Indian J Med Res 1998; 108: 191-202.
[41]
Law M. Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach. Am J Clin Nutr 2000; 72(5): 1291-6.
[42]
Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr 2004; 7(1A): 187-200.
[43]
Shan B, Cai YZ, Sun M, Corke H. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem 2005; 53(20): 7749-59.
[44]
Chandran U, Mehendale N, Tillu G, Patwardhan B. Network Pharmacology of Ayurveda Formulation Triphala with Special Reference to Anti-Cancer Property. Comb Chem High Throughput Screen 2015; 18(9): 846-54.
[46]
Sharma R. Recommendations on herbs and herbal formula in cancer prevention. Open Nutraceuticals J 2010; 3: 129-40.
[47]
Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006; 71(10): 1397-421.
[48]
Bhattacharjee S, Sengupta A. Spices in cancer prevention: an overview. Internet J Nutr Wellness 2009; 7(1): 13.
[49]
Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evid Based Complement Alternat Med 2014; 2014: 642942.
[50]
Kwon HK, Hwang JS, So JS, et al. Cinnamon extract induces tumor cell death through inhibition of NF-κB and AP1. BMC Cancer 2010; 10(1): 392.
[51]
Baliga MS, Jimmy R, Thilakchand KR, et al. Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer. Nutr Cancer 2013; 65(1): 26-35.
[52]
Magesh V, Lee JC, Ahn KS, et al. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells. Phytother Res 2009; 23(10): 1385-91.
[53]
Shimizu T, Torres MP, Chakraborty S, et al. Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: Potential role in therapy. Cancer Lett 2013; 336(2): 270-80.
[54]
Sengupta A, Ghosh S, Bhattacharjee S. Dietary cardamom inhibits the formation of azoxymethane-induced aberrant crypt foci in mice and reduces COX-2 and iNOS expression in the colon. Asian Pac J Cancer Prev 2005; 6(2): 118-22.
[55]
Kaefer CM, Milner JA. Herbs and spices in cancer prevention and
treatment In: Herbal Medicine: biomolecular and clinical aspects;
Benzie IF, Wachtel-Galor S, Eds; 2nd ed CRC Press/Taylor &
Francis 2011
[56]
Acharya A, Das I, Singh S, Saha T. Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis. Recent Pat Food Nutr Agric 2010; 2(2): 166-77.
[57]
Das I, Acharya A, Berry DL, et al. Antioxidative effects of the spice cardamom against non-melanoma skin cancer by modulating nuclear factor erythroid-2-related factor 2 and NF-κB signalling pathways. J Nutr 2012; 108(6): 984-97.
[58]
Mikaili P, Maadirad S, Moloudizargari M, Aghajanshakeri S, Sarahroodi S. Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds. Iran J Basic Med Sci 2013; 16(10): 1031.
[59]
Antony ML, Singh SV. Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide. Indian J Exp Biol 2011; 49(11): 805.
[60]
Omar SH, Al-Wabel NA. Organosulfur compounds and possible mechanism of garlic in cancer. Saudi Pharm J 2010; 18(1): 51-8.
[61]
Shukla Y, Kalra N. Cancer chemoprevention with garlic and its constituents. Cancer Lett 2007; 247(2): 167-81.
[62]
Bhandari PR. Crocus sativus L.(saffron) for cancer chemoprevention: A mini review. J Tradit Complement Med 2015; 5(2): 81-7.
[63]
Bathaie SZ, Bolhassani A, Tamanoi F. Anticancer effect and molecular targets of saffron carotenoids. Enzymes 2013; 36: 57-86.
[64]
Prasad S, Tyagi AK. Ginger and its constituents: Role in prevention and treatment of gastrointestinal cancer. Gastroenterol Res Pract 2015.
[65]
Rahmani AH, Aly SM. Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities. Int J Physiol Pathophysiol Pharmacol 2014; 6(2)
[67]
Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P. Potential of spice-derived phytochemicals for cancer prevention. Planta Med 2008; 74(13): 1560.
[68]
Cattaneo L, Cicconi R, Mignogna G, et al. Anti-proliferative effect of Rosmarinus officinalis L. extract on human melanoma A375 cells. PLoS One 2015; 10(7): e0132439.
[69]
Kawatra P, Rajagopalan R. Cinnamon: Mystic powers of a minute ingredient. Pharmacogn Rev 2015; 7(Suppl. 1): S1.
[71]
Bayan L, Koulivand PH, Gorji A. Garlic: A review of potential therapeutic effects. Avicenna J Phytomed 2014; 4(1): 1.
[72]
Bode AM, Dong Z. The amazing and mighty ginger. In: Herbal
Medicine: Biomolecular and clinical aspects. 2nd ed. 2011.
[73]
Samarghandian S, Borji A. Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients. Pharmacogn Rev 2014; 6(2): 99.
[74]
Majdalawieh AF, Fayyad MW. Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive. J Ayurveda Integr Med 2016; 7(3): 173-80.
[75]
Moore J, Yousef M, Tsiani E. Anticancer effects of rosemary (Rosmarinus officinalis L.) extract and rosemary extract polyphenols. Nutrients 2016; 8(11): 731.
[76]
Urushizaki I. Palliative therapy in cancer. Side effects by anticancer drugs and their treatments. Gan to kagaku ryoho. Gan To Kagaku Ryoho 1990; 17(9): 1959-69.
[77]
Williams AM, Bulsara CE, Petterson AS. Safety and side effects of
non-pharmacological interventions as a therapy for cancer In: In
Evidence-based Non-pharmacological Therapies for Palliative
Cancer Care; Cho WCS, Ed; Springer Netherlands 2013; pp 219-
51
[78]
Bower JE, Woolery A, Sternlieb B, Garet D. Yoga for cancer patients and survivors. Cancer Contr 2005; 12(3): 165.
[79]
Rao MR, Raghuram N, Nagendra HR, et al. Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: A randomized controlled trial. Complement Ther Med 2009; 17(1): 1-8.
[80]
Vadiraja HS, Rao MR, Nagarathna R, et al. Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: A randomized controlled trial. Complement Ther Med 2009; 17(5): 274-80.
[81]
Ülger Ö, Yağlı NV. Effects of yoga on the quality of life in cancer patients. Complement Ther Clin Pract 2010; 16(2): 60-3.
[82]
Carson JW, Carson KM, Porter LS, Keefe FJ, Shaw H, Miller JM. Yoga for women with metastatic breast cancer: results from a pilot study. J Pain Symptom Manage 2007; 33(3): 331-41.
[83]
Sprod LK, Fernandez ID, Janelsins MC, et al. Effects of yoga on cancer-related fatigue and global side-effect burden in older cancer survivors. J Geriatr Oncol 2015; 6(1): 8-14.
[84]
Cramer H, Lauche R, Dobos G. Characteristics of randomized controlled trials of yoga: A bibliometric analysis. BMC Complement Altern Med 2014; 14: 328.
[85]
Zhang J, Yang KH, Tian JH, Wang CM. Effects of yoga on psychologic function and quality of life in women with breast cancer: A meta-analysis of randomized controlled trials. J Altern Complement Med 2012; 18: 994-1002.
[86]
Cramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev 2017; 1: CD010802.
[87]
Lam WW, Soong I, Yau TK, et al. The evolution of psychological distress trajectories in women diagnosed with advanced breast cancer: A longitudinal study. Psychooncology 2013; 22: 2831-9.
[88]
LaVoy EC, Fagundes CP, Dantzer R. Exercise, inflammation, and fatigue in cancer survivors. Exerc Immunol Rev 2016; 22: 82.
[89]
Zhang FF, Cardarelli R, Carroll J, et al. Physical activity and global genomic DNA methylation in a cancer-free population. Epigenetics 2011; 6(3): 293-9.
[90]
Chatterjee B, Pancholi J. Prakriti-based medicine: A step towards personalized medicine. Ayu 2011; 32(2): 141.
[91]
Aggarwal S, Gheware A, Agrawal A, Ghosh S, Prasher B, Mukerji M. Indian Genome Variation Consortium. Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach. J Transl Med 2015; 13(1): 184.
[92]
Patwardhan B, Mutalik G, Tillu G. Integrative approaches for health: biomedical research, ayurveda and yoga. 1st ed. USA: Academic Press 2015; pp. 311-2.
[94]
Negi S, Juyal G, Senapati S, et al. A Genome‐wide association study reveals ARL15, a Novel Non‐HLA susceptibility gene for rheumatoid arthritis in North Indians. Arthritis Rheum 2013; 65(12): 3026-35.
[96]
Juyal RC, Negi S, Wakhode P, Bhat S, Bhat B, Thelma BK. Potential of ayurgenomics approach in complex trait research: Leads from a pilot study on rheumatoid arthritis. PLoS One 2012; 7(9): e45752.
Related Books
Frontiers in Clinical Drug Research - Anti-Cancer Agents
NEOPLASIA and FERTILITY
Breast Cancer: Current Trends in Molecular Research
The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Topics in Anti-Cancer Research
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Modern Cancer Therapies and Traditional Medicine: An Integrative Approach to Combat Cancers
Herbal Medicine: Back to the Future
Thrombosis in Cancer: A Medical Professional's Guide to Cancer Associated Thrombosis
Article Metrics
58
2